🔴Relating to access to individualized investigational treatments for patients with life-threatening or severely debilitating illnesses.

🔴 SB 984: Private Access to Experimental Treatments Without Oversight

What it says it does:
SB 984 lets patients with life-threatening or severely debilitating illnesses request custom-made experimental treatments when no FDA-approved options remain. It is described as a way to give Texans with rare conditions a chance to try individualized therapies based on their genetics.

What it actually changes:
It creates a new legal pathway outside normal medical and insurance systems. Patients must cover all costs, sign away the right to sue for harm, and rely on hospitals and manufacturers that can choose whether to provide treatment. State agencies cannot intervene once conditions are met, which removes public oversight.

Who is pushing for it:
Sen. Paul Bettencourt authored the bill. Supporters in the official records include the Goldwater Institute, Texas Right to Know, Heartland Impact, and the Texas Medical Association. These groups advocate for expanded “Right to Try” access and deregulation of medical innovation.

Who benefits:
Research hospitals that can bill directly for custom therapies. Manufacturers and biotech firms that gain legal immunity and control pricing. Advocacy organizations that promote deregulated medical access as a political goal.

Who gets left out or exposed:
Patients who cannot afford tens or hundreds of thousands in private costs. Families who lose hospice coverage or financial protection. Texans who assume this is a public safety net when it is actually a private market transaction.

Why this matters long term:
The bill shifts medical decision power away from regulators and insurance systems and concentrates it in private institutions. It creates a precedent for high-cost medical care that operates outside normal accountability, opening the door for similar carveouts in future legislation.

What to watch next:
Whether future sessions expand this model to other treatments or industries. Whether the state collects any data on outcomes or costs. Whether hospitals or insurers begin using the statute to justify private pay-only medical tiers.

Bottom line:
SB 984 gives desperate patients the right to ask for last-chance medicine, but only if they can afford it. It removes oversight, shields industry from lawsuits, and builds a pay-to-try system where hope is sold without accountability.

#SB984 #TexasPolicy #HealthCare #MedicalAccess #StayInformed